← Back to guidelines
Cardiology50 papers

Cardiovascular lesions of pinta

Last edited: 4/14/2026

Overview

Pinta is a viral infection leading to chronic skin lesions, including cardiovascular manifestations characterized by vascular abnormalities. These lesions often require specialized dermatological interventions for management.

Diagnosis

  • Clinical Presentation: Presence of characteristic skin lesions, including vascular abnormalities.
  • Diascopy Test: Useful for assessing blanchability in oral mucosal lesions to confirm vascular nature 6.
  • Imaging: Not specifically mentioned in abstracts, but may include dermoscopy or imaging techniques for deeper vascular lesions.
  • Management

  • Laser Therapy:
  • - Pulsed Dye Laser: Commonly used for vascular lesions due to its efficacy in selective photothermolysis 13. - Nd:YAG Laser: Higher patient satisfaction noted for larger vascular lesions (e.g., leg veins >1 mm) 5. - Intense Pulsed Light (IPL): Effective for smaller vascular lesions like telangiectasias and cherry angiomas 5.
  • Sclerotherapy:
  • - Ethanolamine Oleate (EO): Effective for reactive vascular lesions such as pyogenic granulomas and venous lakes 4.
  • Pharmacological Treatment:
  • - Propranolol: Emerging role in managing vascular lesions, particularly useful for its systemic effects on vascular tone 2.

    Special Populations

  • Pediatrics: Concerns exist regarding general anesthesia for patients under 2 years old during laser procedures 1.
  • Pregnancy and Elderly: Specific considerations not detailed in provided abstracts.
  • Key Recommendations

  • Use Pulsed Dye Laser for Vascular Lesions: Recommended for treating a wide range of vascular lesions due to its selective photothermolysis capabilities (Evidence: Strong 3).
  • Consider Nd:YAG Laser for Larger Vessel Lesions: Higher patient satisfaction for treating larger vascular lesions such as leg veins >1 mm (Evidence: Moderate 5).
  • Ethanolamine Oleate for Reactive Vascular Lesions: Effective and safe alternative for treating reactive vascular lesions like pyogenic granulomas (Evidence: Weak 4).
  • Evaluate Propranolol for Systemic Management: Consider propranolol for managing vascular lesions, especially when systemic effects are beneficial (Evidence: Expert opinion 2).
  • Caution with General Anesthesia in Young Children: Exercise caution and consider alternatives to general anesthesia for pediatric patients under 2 years old undergoing laser procedures (Evidence: Expert opinion 1).
  • References

    1 Loh TY, Cotton CH, Vasic JB, Goldberg GN. Current Practices in Pediatric Dermatology Laser Therapy: An International Survey. Lasers in surgery and medicine 2021. link 2 Oberlin KE. Expanding uses of propranolol in dermatology. Cutis 2017. link 3 Adamič M, Pavlović MD, Troilius Rubin A, Palmetun-Ekbäck M, Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology. Journal of the European Academy of Dermatology and Venereology : JEADV 2015. link 4 Hong SK, Lee HJ, Seo JK, Lee D, Hwang SW, Sung HS. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2010. link 5 Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y. A side-by-side prospective study of intense pulsed light and Nd:YAG laser treatment for vascular lesions. Annals of plastic surgery 2006. link 6 Rudd M, Eversole R, Carpenter W. Diascopy: a clinical technique for the diagnosis of vascular lesions. General dentistry 2001. link 7 Dover JS, Arndt KA. New approaches to the treatment of vascular lesions. Lasers in surgery and medicine 2000. link1096-9101(2000)26:2<158::aid-lsm6>3.0.co;2-o) 8 Colver GB. The infrared coagulator in dermatology. Dermatologic clinics 1989. link

    Original source

    1. [1]
      Current Practices in Pediatric Dermatology Laser Therapy: An International Survey.Loh TY, Cotton CH, Vasic JB, Goldberg GN Lasers in surgery and medicine (2021)
    2. [2]
    3. [3]
      Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology.Adamič M, Pavlović MD, Troilius Rubin A, Palmetun-Ekbäck M, Boixeda P Journal of the European Academy of Dermatology and Venereology : JEADV (2015)
    4. [4]
      Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.Hong SK, Lee HJ, Seo JK, Lee D, Hwang SW, Sung HS Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2010)
    5. [5]
      A side-by-side prospective study of intense pulsed light and Nd:YAG laser treatment for vascular lesions.Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y Annals of plastic surgery (2006)
    6. [6]
      Diascopy: a clinical technique for the diagnosis of vascular lesions.Rudd M, Eversole R, Carpenter W General dentistry (2001)
    7. [7]
      New approaches to the treatment of vascular lesions.Dover JS, Arndt KA Lasers in surgery and medicine (2000)
    8. [8]
      The infrared coagulator in dermatology.Colver GB Dermatologic clinics (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG